Lipid control and its associated factors among patients with dyslipidaemia in Jordan

Anan S Jarab1, Eman A Alefishat2,3,4, Walid Al-Qerem5

  • 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Insights

Poor lipid control is common in Jordanian dyslipidaemia patients, especially smokers with atherosclerotic cardiovascular disease (ASCVD). Improving medication adherence and simplifying regimens are key to better lipid management and outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Lipid control is crucial for managing atherosclerotic cardiovascular disease (ASCVD).
  • Factors contributing to poor lipid control in dyslipidaemia patients remain under-researched.

Purpose of the Study:

  • To investigate variables associated with poor lipid control in Jordanian dyslipidaemia patients.
  • To identify predictors of dyslipidaemia control in a clinical setting.

Main Methods:

  • Retrospective chart review of 228 dyslipidaemia patients in Jordan.
  • Collected socio-demographics, disease/medication data, and lipid profiles.
  • Assessed medication adherence and beliefs; used AHA guidelines for control classification.
  • Stepwise logistic regression identified independent predictors of lipid control.

Main Results:

  • 61% of patients had uncontrolled lipid profiles; 60.1% had ASCVD.
  • Increased perceived medication necessity correlated with better control (OR=1.14).
  • Active smoking (OR=0.42), low adherence (OR=0.0.8), and ASCVD presence (OR=0.24) were linked to poor control.

Conclusions:

  • Significant potential exists to improve lipid control in Jordanian dyslipidaemia patients.
  • Interventions should focus on enhancing medication adherence, emphasizing necessity, and simplifying regimens.
  • Targeted strategies for smokers and ASCVD patients are essential for improved lipid management and health outcomes.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
136
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.5K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.0K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.8K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
435